Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Raoudha Tekaya1, Aicha Ben Tekaya1, Inès Mahmoud1

  • 1Department of Rheumatology, Charles Nicolle Hospital, Tunis. Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia.

La Tunisie Medicale
|January 15, 2025
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropathic pain in rheumatoid arthritis: prevalence and associated factors.

Reumatologia·2026
Same author

Spondylodiscitis caused by Citrobacter koseri: a case report.

Journal of medical case reports·2026
Same author

Impact of an ergonomic training program on musculoskeletal disorders among paramedical staff: A comparative study.

Archives of environmental & occupational health·2026
Same author

Falls in rheumatoid arthritis: Prevalence and associated factors.

La Tunisie medicale·2026
Same author

Self-medication with analgesics in rheumatology: Frequency and associated factors.

La Tunisie medicale·2026
Same author

A comparative study of medical student performance and satisfaction in an in-person vs online chronic pain certificate program.

La Tunisie medicale·2026
Same journal

Abstracts International Scientific Day on Oxidative Stress, Aging, and Age-Related Diseases.

La Tunisie medicale·2026
Same journal

Pharmacological evaluation of anti-inflammatory potential and antispasmodic effect of aqueous extract from the brown seaweed, Cystoseira compressa.

La Tunisie medicale·2026
Same journal

Assessing the Accuracy of LDL-Cholesterol Estimation Formulas in the Tunisian Population.

La Tunisie medicale·2026
Same journal

Assessment of liver fibrosis in Chronic hepatitis B: performance of hematological parameters.

La Tunisie medicale·2026
Same journal

Association between Oxidative Stress, Cardiovascular Risk, and Disease Activity in Patients with Spondyloarthritis: A Cross-Sectional Study in a Tunisian Cohort.

La Tunisie medicale·2026
Same journal

Assessment of oral cancer awareness among dentists in Tunisia: A cross-sectional study.

La Tunisie medicale·2026
See all related articles
This summary is machine-generated.

Tunisian rheumatologists developed 10 key recommendations for managing spondyloarthritis patients undergoing biologic agent therapy. These guidelines cover pre-treatment assessment, biologic use, and special situations like pregnancy or neoplasia.

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Spondyloarthritis management requires updated therapeutic strategies.
  • Biological agents represent a significant advancement in treating spondyloarthritis.
  • Current Tunisian clinical practice needed standardized recommendations for biologic therapy.

Purpose of the Study:

  • To establish evidence-based Tunisian recommendations for the therapeutic management of spondyloarthritis patients.
  • To guide the use of biological agents in current clinical practice.
  • To address pre-treatment, treatment, and special considerations for biologic therapy in spondyloarthritis.

Main Methods:

  • Systematic literature review conducted by 6 rheumatologists.
  • Expert consensus developed through working group meetings with 15 rheumatologists.
Keywords:
RecommendationsSpondyloarthritisTreatment

Related Experiment Videos

  • Recommendations validated by an independent reading group of 19 experts.
  • Main Results:

    • Ten comprehensive recommendations for good practice were formulated.
    • Guidelines address pre-therapeutic assessment and immunisation status.
    • Recommendations cover biologic indications, follow-up, failure management, pregnancy, and neoplasia.

    Conclusions:

    • The recommendations integrate current literature and clinical presentation.
    • These guidelines facilitate the management of spondyloarthritis patients receiving biological agents.
    • The work, supported by LITAR and accredited by INEAS, provides practical clinical guidance.